Evommune EVMN Derivative, Gain (Loss) on Derivative, Net
Derivative, Gain (Loss) on Derivative, Net at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:DerivativeGainLossOnDerivativeNet.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's derivative, gain (loss) on derivative, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's derivative, gain (loss) on derivative, net?
- Evommune (EVMN) reported derivative, gain (loss) on derivative, net of $25.37K in Q1 2026.
- How has Evommune 's derivative, gain (loss) on derivative, net changed year-over-year?
- Evommune 's derivative, gain (loss) on derivative, net decreased by 98.6% year-over-year, from $1.84M to $25.37K.
- What does derivative, gain (loss) on derivative, net mean?
- The net impact of changes in the fair value of derivative instruments held by the company, including unrealized gains or losses. This metric captures the volatility introduced to the income statement by financial instruments that are sensitive to market price fluctuations.